Cold atmospheric plasma inhibits the growth of osteosarcoma cells by inducing apoptosis, independent of the device used
Open Access
- 19 November 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 19 (1) , 283-290
Abstract
Osteosarcoma (OS) is the most common tumor of the musculoskeletal system. Recently, cold atmospheric plasma (CAP) has been regarded as a promising anti‑oncogenic therapy. Previous experimental studies have demonstrated that CAP treatment results in significant growth inhibition of human sarcoma and is able to induce apoptosis. However, due to device‑specific parameters, there is a large variability in the antitumor effects of different CAP sources. In the present study, the cellular effects of CAP treatment from two different CAP devices were investigated and their pro‑apoptotic efficacy was characterized. The OS cell lines, U2‑OS and MNNG/HOS, were treated with two CAP devices, kINPen MED and MiniJet‑R. Control groups were treated with argon. The anti‑proliferative effect of each treatment was demonstrated using cell counting and the activation of apoptotic mechanisms was determined using Comet, TUNEL and Caspase‑3/Caspase‑7 assays. The results revealed that treatment of both OS cell lines with the two CAP sources resulted in significant inhibition of cell growth. Subsequently, the activation of Caspases and the induction of apoptotic DNA fragmentation was demonstrated. The biological effects of each CAP source did not differ significantly. The treatment of OS cells with CAP lead to an induction of apoptosis and a reduction of cell growth. Therefore, the biological effects of CAP appear to be general as the two devices of different design produced highly comparable cell responses. Therefore, the type of device used does not seem to affect the efficacy of CAP‑based antitumor therapy.Keywords
This publication has 47 references indexed in Scilit:
- Atmospheric gas plasma–induced ROS production activates TNF-ASK1 pathway for the induction of melanoma cancer cell apoptosisMolecular Biology of the Cell, 2014
- Osteosarcoma treatment – Where do we stand? A state of the art reviewCancer Treatment Reviews, 2014
- Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen speciesCell Death & Disease, 2014
- A systematic review of p53 as a biomarker of survival in patients with osteosarcomaTumor Biology, 2013
- In Vitro Susceptibility of Important Skin and Wound Pathogens Against Low Temperature Atmospheric Pressure Plasma Jet (APPJ) and Dielectric Barrier Discharge Plasma (DBD)Plasma Processes and Polymers, 2012
- ROS implication in a new antitumor strategy based on non‐thermal plasmaInternational Journal of Cancer, 2011
- Using Epidemiology and Genomics to Understand Osteosarcoma EtiologySarcoma, 2011
- Therapeutic Effect of Pirarubicin-Based Chemotherapy for Osteosarcoma Patients with Lung MetastasisJournal of Chemotherapy, 2010
- Osteosarcoma Development and Stem Cell DifferentiationClinical Orthopaedics and Related Research, 2008
- Arc‐Free Atmospheric Pressure Cold Plasma Jets: A ReviewPlasma Processes and Polymers, 2007